Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1

Author: Arai Wataru   Hosoya Yoshinori   Hyodo Masanobu   Haruta Hidenori   Kurashina Kentaro   Saito Shin   Hirashima Yuuki   Yokoyama Taku   Zuiki Toru   Sakuma Kazuya   Yasuda Yoshikazu   Nagai Hideo  

Publisher: Springer Publishing Company

ISSN: 1341-9625

Source: International Journal of Clinical Oncology, Vol.12, Iss.2, 2007-04, pp. : 146-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content